Ignite Creation Date:
2024-05-05 @ 10:50 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01196312
Status:
COMPLETED
Last Update Posted:
2023-05-30
First Post:
2010-08-23
Brief Title:
Anxiety Sensitivity Treatment for Heroin Users
Sponsor:
University of Maryland College Park
Organization:
University of Maryland College Park
Study Overview
Official Title:
Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ASTH-HR
Brief Summary:
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment ASTH-HR will integrate established treatment modules such as Healthy Relationships along with interoceptive exposure affect management and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None